PROTeIn-rich Meals to Control Glucose
Launched by GERMAN INSTITUTE OF HUMAN NUTRITION · Apr 21, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "PROTeIn-rich Meals to Control Glucose," is exploring how different diets can help people with prediabetes and type 2 diabetes manage their blood sugar levels. The researchers want to find out if eating meals high in protein at certain times of the day can be more effective than other diets that include different amounts of carbohydrates and protein. This study aims to better understand how these dietary patterns affect blood sugar control and inflammation in the body.
If you're aged between 27 and 74 years and have prediabetes (with a fasting blood sugar level between 100-125 mg/dl) or type 2 diabetes (with a fasting blood sugar level above 126 mg/dl), you may be eligible to participate. It’s important to note that if you have other types of diabetes, are on insulin treatment, or have certain health conditions (like severe high blood pressure, heart disorders, or recent cancer), you may not qualify for this study. Participants can expect to follow specific meal plans and may have regular check-ins to monitor their progress. This trial is currently looking for volunteers, so if you're interested, it's a good time to reach out!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Prediabetes (fasting blood sugar 100-125 mg/dl)
- • Diabetes type 2 (fasting blood sugar \>126 mg/dl)
- • Overweight and obesity (BMI 25-50 kg/m2)
- Exclusion Criteria:
- • Other diabetes types
- • Insulin treatment
- • Shift work
- • Weight changes \>5% within past 3 months
- • Systemic glucocorticoid therapy
- • Systemic infections
- • Severe anemia
- • High blood pressure (\>180/110 mmHg)
- • Endocrinologic, liver and heart disorders
- • Immune diseases
- • Thyroid dysfunction
- • Heart attack or stroke
- • Cancer in the last 2 years
- • Eating disorders, food intolerance/allergy, addiction disorders, digestive disorders intestinal, liver, cardiovascular diseases
- • Hereditary or acquired coagulation disorders
- • Non-interruptible intake of blood thinners (anticoagulants)
- • Specific diets, intermittent fasting
- • Pregnancy or breastfeeding
- • Severe internal or psychiatric disorders or other conditions and drugs therapy that might influence the outcome of the study
About German Institute Of Human Nutrition
The German Institute of Human Nutrition (DIfE) is a renowned research institution dedicated to advancing the understanding of nutrition and its impact on human health. Located in Potsdam-Rehbrücke, DIfE conducts interdisciplinary research that integrates molecular biology, nutrition science, and public health to address pressing dietary challenges and promote optimal health outcomes. As a clinical trial sponsor, DIfE is committed to rigorous scientific methodologies and ethical standards, facilitating innovative studies that explore the relationships between diet, metabolism, and disease prevention. Through its collaborative efforts with academic and industry partners, DIfE aims to translate research findings into practical dietary guidelines and interventions that improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Potsdam, Potsdam Rehbrücke, Germany
Potsdam, , Germany
Patients applied
Trial Officials
Olga Ramich, PD Dr.
Principal Investigator
German Institute of Human Nutrition
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported